These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

548 related articles for article (PubMed ID: 32317643)

  • 1. Collagen-producing lung cell atlas identifies multiple subsets with distinct localization and relevance to fibrosis.
    Tsukui T; Sun KH; Wetter JB; Wilson-Kanamori JR; Hazelwood LA; Henderson NC; Adams TS; Schupp JC; Poli SD; Rosas IO; Kaminski N; Matthay MA; Wolters PJ; Sheppard D
    Nat Commun; 2020 Apr; 11(1):1920. PubMed ID: 32317643
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cthrc1 lowers pulmonary collagen associated with bleomycin-induced fibrosis and protects lung function.
    Binks AP; Beyer M; Miller R; LeClair RJ
    Physiol Rep; 2017 Mar; 5(5):. PubMed ID: 28292882
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CTHRC1: An Emerging Hallmark of Pathogenic Fibroblasts in Lung Fibrosis.
    Mukhatayev Z; Adilbayeva A; Kunz J
    Cells; 2024 May; 13(11):. PubMed ID: 38891078
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fibroblast Activation Protein (FAP) Accelerates Collagen Degradation and Clearance from Lungs in Mice.
    Fan MH; Zhu Q; Li HH; Ra HJ; Majumdar S; Gulick DL; Jerome JA; Madsen DH; Christofidou-Solomidou M; Speicher DW; Bachovchin WW; Feghali-Bostwick C; Puré E
    J Biol Chem; 2016 Apr; 291(15):8070-89. PubMed ID: 26663085
    [TBL] [Abstract][Full Text] [Related]  

  • 5. miR-21 mediates fibrogenic activation of pulmonary fibroblasts and lung fibrosis.
    Liu G; Friggeri A; Yang Y; Milosevic J; Ding Q; Thannickal VJ; Kaminski N; Abraham E
    J Exp Med; 2010 Aug; 207(8):1589-97. PubMed ID: 20643828
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Qualitative rather than quantitative changes are hallmarks of fibroblasts in bleomycin-induced pulmonary fibrosis.
    Tsukui T; Ueha S; Abe J; Hashimoto S; Shichino S; Shimaoka T; Shand FH; Arakawa Y; Oshima K; Hattori M; Inagaki Y; Tomura M; Matsushima K
    Am J Pathol; 2013 Sep; 183(3):758-73. PubMed ID: 23886891
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasminogen activator inhibitor-1 suppresses profibrotic responses in fibroblasts from fibrotic lungs.
    Marudamuthu AS; Shetty SK; Bhandary YP; Karandashova S; Thompson M; Sathish V; Florova G; Hogan TB; Pabelick CM; Prakash YS; Tsukasaki Y; Fu J; Ikebe M; Idell S; Shetty S
    J Biol Chem; 2015 Apr; 290(15):9428-41. PubMed ID: 25648892
    [TBL] [Abstract][Full Text] [Related]  

  • 8. α-Smooth muscle actin is an inconsistent marker of fibroblasts responsible for force-dependent TGFβ activation or collagen production across multiple models of organ fibrosis.
    Sun KH; Chang Y; Reed NI; Sheppard D
    Am J Physiol Lung Cell Mol Physiol; 2016 May; 310(9):L824-36. PubMed ID: 26944089
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fulminant lung fibrosis in non-resolvable COVID-19 requiring transplantation.
    Jyothula SSK; Peters A; Liang Y; Bi W; Shivshankar P; Yau S; Garcha PS; Yuan X; Akkanti B; Collum S; Wareing N; Thandavarayan RA; Poli de Frias F; Rosas IO; Zhao B; Buja LM; Eltzschig HK; Huang HJ; Karmouty-Quintana H
    EBioMedicine; 2022 Dec; 86():104351. PubMed ID: 36375315
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Single-Cell RNA Sequencing Analysis Reveals a Crucial Role for CTHRC1 (Collagen Triple Helix Repeat Containing 1) Cardiac Fibroblasts After Myocardial Infarction.
    Ruiz-Villalba A; Romero JP; Hernández SC; Vilas-Zornoza A; Fortelny N; Castro-Labrador L; San Martin-Uriz P; Lorenzo-Vivas E; García-Olloqui P; Palacio M; Gavira JJ; Bastarrika G; Janssens S; Wu M; Iglesias E; Abizanda G; de Morentin XM; Lasaga M; Planell N; Bock C; Alignani D; Medal G; Prudovsky I; Jin YR; Ryzhov S; Yin H; Pelacho B; Gomez-Cabrero D; Lindner V; Lara-Astiaso D; Prósper F
    Circulation; 2020 Nov; 142(19):1831-1847. PubMed ID: 32972203
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulator of Cell Cycle Protein (RGCC/RGC-32) Protects against Pulmonary Fibrosis.
    Luzina IG; Rus V; Lockatell V; Courneya JP; Hampton BS; Fishelevich R; Misharin AV; Todd NW; Badea TC; Rus H; Atamas SP
    Am J Respir Cell Mol Biol; 2022 Feb; 66(2):146-157. PubMed ID: 34668840
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In situ hybridization analysis of rat lung alpha 1(I) and alpha 2(I) collagen gene expression in pulmonary fibrosis induced by endotracheal bleomycin injection.
    Zhang K; Gharaee-Kermani M; McGarry B; Phan SH
    Lab Invest; 1994 Feb; 70(2):192-202. PubMed ID: 7511187
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Netrin-1 Regulates Fibrocyte Accumulation in the Decellularized Fibrotic Sclerodermatous Lung Microenvironment and in Bleomycin-Induced Pulmonary Fibrosis.
    Sun H; Zhu Y; Pan H; Chen X; Balestrini JL; Lam TT; Kanyo JE; Eichmann A; Gulati M; Fares WH; Bai H; Feghali-Bostwick CA; Gan Y; Peng X; Moore MW; White ES; Sava P; Gonzalez AL; Cheng Y; Niklason LE; Herzog EL
    Arthritis Rheumatol; 2016 May; 68(5):1251-61. PubMed ID: 26749424
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transcription factor ets-2 plays an important role in the pathogenesis of pulmonary fibrosis.
    Baran CP; Fischer SN; Nuovo GJ; Kabbout MN; Hitchcock CL; Bringardner BD; McMaken S; Newland CA; Cantemir-Stone CZ; Phillips GS; Ostrowski MC; Marsh CB
    Am J Respir Cell Mol Biol; 2011 Nov; 45(5):999-1006. PubMed ID: 21562315
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IL-25 and type 2 innate lymphoid cells induce pulmonary fibrosis.
    Hams E; Armstrong ME; Barlow JL; Saunders SP; Schwartz C; Cooke G; Fahy RJ; Crotty TB; Hirani N; Flynn RJ; Voehringer D; McKenzie AN; Donnelly SC; Fallon PG
    Proc Natl Acad Sci U S A; 2014 Jan; 111(1):367-72. PubMed ID: 24344271
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CCN5 overexpression inhibits profibrotic phenotypes via the PI3K/Akt signaling pathway in lung fibroblasts isolated from patients with idiopathic pulmonary fibrosis and in an in vivo model of lung fibrosis.
    Zhang L; Li Y; Liang C; Yang W
    Int J Mol Med; 2014 Feb; 33(2):478-86. PubMed ID: 24276150
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of the heterogeneity of endothelial cells in bleomycin-induced lung fibrosis using single-cell RNA sequencing.
    Liu X; Qin X; Qin H; Jia C; Yuan Y; Sun T; Chen B; Chen C; Zhang H
    Angiogenesis; 2021 Nov; 24(4):809-821. PubMed ID: 34028626
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel profibrotic mechanism mediated by TGFβ-stimulated collagen prolyl hydroxylase expression in fibrotic lung mesenchymal cells.
    Luo Y; Xu W; Chen H; Warburton D; Dong R; Qian B; Selman M; Gauldie J; Kolb M; Shi W
    J Pathol; 2015 Jul; 236(3):384-94. PubMed ID: 25779936
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PDGFRα and αSMA mark two distinct mesenchymal cell populations involved in parenchymal and vascular remodeling in pulmonary fibrosis.
    Biasin V; Crnkovic S; Sahu-Osen A; Birnhuber A; El Agha E; Sinn K; Klepetko W; Olschewski A; Bellusci S; Marsh LM; Kwapiszewska G
    Am J Physiol Lung Cell Mol Physiol; 2020 Apr; 318(4):L684-L697. PubMed ID: 32023084
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Attenuation of fibrosis in vitro and in vivo with SPARC siRNA.
    Wang JC; Lai S; Guo X; Zhang X; de Crombrugghe B; Sonnylal S; Arnett FC; Zhou X
    Arthritis Res Ther; 2010; 12(2):R60. PubMed ID: 20359365
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.